Skip to content

Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy

Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy for Periampullary Tumour (Multicenter Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04401722
Acronym
PD
Enrollment
90
Registered
2020-05-26
Start date
2018-03-01
Completion date
2020-04-25
Last updated
2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periampullary Cancer

Keywords

pancreaticodudenctomy, POPF, HIGH ALTITUDE

Brief summary

Very few papers examine the effect of living at high altitudes on surgical results of major operations. This research is designed to determine the surgical outcomes of PD for periampullary tumour in high altitudes and normal altitudes.

Detailed description

Many recent studies have suggested multiple risk factors affecting postoperative surgical outcomes of PD; THE research is designed to determine the surgical outcomes of PD for periampullary tumour in high altitudes and normal altitude. it is a multicenter study Aseer central hospital, Saudia and from Egypt two centers Mansoura university and el Menia university

Interventions

PROCEDUREPANCREATICODUDENECTOMY

dissection and removal of periampulary tumour with 3 reconstruction PJ, HJ, and GJ

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

OUTCOME ASESSOR

Intervention model description

it is a multicenter study Aseer centeral hospital, saudia and from Egypt two centers mansoura university and el menia university The patients distributed into two groups group I (G1) PD underwent in the area at the level of the sea, normal altitude region, and group II (G2) PD underwent in high altitude region.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* periampulary tumour

Exclusion criteria

* liver cirrhosis, * PG, * advanced tumour, * vascular resection

Design outcomes

Primary

MeasureTime frameDescription
the overall postoperative complications30 DAYSthe overall postoperative complications

Secondary

MeasureTime frameDescription
blood lossINTRAOPERATIVEblood loss
Pulmonary embolism (PE)30 daysPulmonary embolism (PE)
hospital mortality30 daysdeath within 30 days of operation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026